Walleye Capital’s Replimune Group REPL Stock Holding History

Walleye Capital’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.2K	Sell	2,729 -68,863	-96%	-$421K	﹤0.01%	4320
2026 Q1	$548K	Buy	+71,592	New	+$547K	﹤0.01%	2592
2025 Q4	–	Sell	-21,055	Closed	-$179K	–	5020
2025 Q3	$88.2K	Buy	+21,055	New	+$135K	﹤0.01%	3768
2024 Q3	–	Sell	-49,754	Closed	-$448K	–	5769
2024 Q2	$448K	Buy	49,754 +19,503	+64%	+$136K	﹤0.01%	3599
2024 Q1	$247K	Buy	30,251 +193	+0.6%	+$1.58K	﹤0.01%	3822
2023 Q4	$253K	Buy	+30,058	New	+$348K	﹤0.01%	3502
2023 Q3	–	Sell	-50,663	Closed	-$1.18M	–	5247
2023 Q2	$1.18M	Buy	+50,663	New	+$990K	﹤0.01%	1721

Other funds holding REPL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Walleye Capital's REPL Position: Q2 2026 in Review

Walleye Capital reduced its Replimune Group (REPL) stake by 96% in Q2 2026, selling an estimated $421K and leaving 2,729 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4320.

Walleye Capital first reported a position in REPL in Q2 2023 and has held it in 7 quarters since. The position peaked at $1.18M in Q2 2023. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

Walleye Capital held 2,729 shares of Replimune Group worth $30.2K as of Q2 2026.
Walleye Capital sold 68,863 Replimune Group shares in Q2 2026, an estimated $421K.
Replimune Group made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4320 holding.
Walleye Capital first reported a position in Replimune Group in Q2 2023 and has held it in 7 quarters since.
Walleye Capital's Replimune Group position peaked at $1.18M in Q2 2023.
199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.